(Q43474062)

23 November 2017

title

Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice (English)

1 reference

23 November 2017

Xiaochang Liu

1

1 reference

23 November 2017

Jianming Xu

2

1 reference

23 November 2017

Qiao Mei

3

1 reference

23 November 2017

Liang Han

4

1 reference

23 November 2017

Jian Huang

5

1 reference

23 November 2017

publication date

10 July 2012

1 reference

Digestive Diseases and Sciences

23 November 2017

published in

1 reference

23 November 2017

volume

58

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

107-114

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-012-2304-3

23 November 2017

exact match

0 references

cites work

Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Protective effect of octreotide and infliximab in an experimental model of indomethacin-induced inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Traumatic brain injury and intestinal dysfunction: uncovering the neuro-enteric axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

HNF4α and CDH1 are associated with ulcerative colitis in a Dutch cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Intestinal barrier dysfunction in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Current directions of biologic therapies in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Infliximab for ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2304-3

Recent advances in biological therapy for inflammatory bowel disease.

21 January 2018

1 reference

12 December 2020

Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease

1 reference

12 December 2020

Abnormal intestinal permeability predicts relapse in inactive Crohn disease

1 reference

12 December 2020

Modulation of the Th1/Th2 balance by infliximab improves hyperthyroidism associated with a flare-up of ulcerative colitis

1 reference

12 December 2020

Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn's disease

1 reference

12 December 2020

Mechanism of glucocorticoid regulation of the intestinal tight junction barrier

1 reference

12 December 2020

Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease

1 reference

12 December 2020

Effect of efavirenz on intestinal p-glycoprotein and hepatic p450 function in rats

1 reference

12 December 2020

Is there a role for infliximab in the treatment of severe ulcerative colitis?: the American experience

1 reference

12 December 2020

Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution

1 reference

12 December 2020

Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression

1 reference

12 December 2020

Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse

1 reference

12 December 2020

Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis

1 reference

12 December 2020

Regulation of human jejunal transmucosal resistance and MLC phosphorylation by Na(+)-glucose cotransport

1 reference

12 December 2020

Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease

1 reference

12 December 2020

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

1 reference

12 December 2020

Interleukins IL-33 and IL-17/IL-17A in patients with ulcerative colitis.

1 reference

12 December 2020

Experimental models of inflammatory bowel disease

1 reference

12 December 2020

10.1007/S10620-012-2304-3

Identifiers

DOI

1 reference

23 November 2017

1 reference